Search Results 241-250 of 17268 for egfr

1. EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) < 20 mL/min/1.73 m2 at baseline. Co-morbid conditions that may interfere with completing the study protocol ...

2. A Study To Evaluate Telisotuzumab Vedotin (ABBV-399) In Subjects With Previously Treated C-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

   Histologically confirmed non-squamous cell non-small cell lung cancer (NSCLC) with known epidermal growth factor receptor (EGFR) status (wild type or mutant ...

3. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) (eGFR) \<30mL/min 19. Major surgery within 8 weeks prior to screening or planned major surgery within 6 months ...

4. A Study To Evaluate The Long-term Safety And Tolerability Of Inhaled LIQ861(Treprostinil) In Pulmonary Arterial Hypertension Patients - Mayo Clinic

   The patient has severe renal impairment (eGFR < 35). The patient is taking inhaled treprostinil doses of greater than 90 μg (more than 15 breaths) ...

5. Application Process - Gastroenterology, Esophageal Diseases Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

   Application process for the Esophageal Diseases Fellowship at Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.

6. People with kidney disease should be cautious with supplements, Mayo researchers say

   Many Americans decide to take supplements on their own, not because of a doctor's recommendation, the researchers found, most often with the goal of improving ...

7. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

   The patient has severe renal impairment (eGFR < 30). Additional Exclusion Criteria for PK Sub-Study: The patient meets any of Primary Exclusion Criteria ...

8. A Randomized, Double-Blind, Multicenter, Phase 3 Study Of The Efficacy, Safety, And Tolerability Of Brincidofovir Versus Valganciclovir For The Prevention Of Cytomegalovirus Disease In CMV Seronegative Kidney Allograft Recipients - Mayo Clinic

   Within 14 days post transplant, eGFR > 10 mL/min by the C-G equation; Able to ingest tablets. Exclusion Criteria: Multiorgan transplant recipient; Plasma CMV ...

9. HEART: Pilot Randomized Controlled Trial - Mayo Clinic

   eGFR ≥ 50 mL/min/1.73 m²; 4. serum potassium ≤ 5.1 mmol/L; 5. ability to provide informed consent. Exclusion Criteria 1. Heritable aortopathies (Marfan ...

10. Phase 2a Study Of VX-407 In Participants With ADPKD Who Have A Subset Of PKD1 Gene Variants (AGLOW) - Mayo Clinic

    * Estimated glomerular filtration rate (eGFR) greater than or equal to (≥) 25 milliliter per minute (mL/min)/1.73 square meter (m\^2) Key Exclusion ...